126 related articles for article (PubMed ID: 29396044)
21. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.
Bergamaschi C; Rosati M; Jalah R; Valentin A; Kulkarni V; Alicea C; Zhang GM; Patel V; Felber BK; Pavlakis GN
J Biol Chem; 2008 Feb; 283(7):4189-99. PubMed ID: 18055460
[TBL] [Abstract][Full Text] [Related]
22. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.
Yokota S; Yoshida O; Dou L; Spadaro AV; Isse K; Ross MA; Stolz DB; Kimura S; Du Q; Demetris AJ; Thomson AW; Geller DA
J Immunol; 2015 Jun; 194(12):6045-56. PubMed ID: 25964490
[TBL] [Abstract][Full Text] [Related]
23. Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.
Gaston DC; Odom CI; Li L; Markert JM; Roth JC; Cassady KA; Whitley RJ; Parker JN
PLoS One; 2013; 8(11):e81768. PubMed ID: 24312353
[TBL] [Abstract][Full Text] [Related]
24. The role of classical and alternative macrophages in the immunopathogenesis of herpes simplex virus-induced inflammation in a mouse model.
Anower AK; Shim JA; Choi B; Kwon HJ; Sohn S
J Dermatol Sci; 2014 Mar; 73(3):198-208. PubMed ID: 24280370
[TBL] [Abstract][Full Text] [Related]
25. Secretion and biological activity of short signal peptide IL-15 is chaperoned by IL-15 receptor alpha in vivo.
Bergamaschi C; Jalah R; Kulkarni V; Rosati M; Zhang GM; Alicea C; Zolotukhin AS; Felber BK; Pavlakis GN
J Immunol; 2009 Sep; 183(5):3064-72. PubMed ID: 19696432
[TBL] [Abstract][Full Text] [Related]
26. Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells.
Müller JR; Waldmann TA; Kruhlak MJ; Dubois S
J Biol Chem; 2012 Nov; 287(48):40328-38. PubMed ID: 23074221
[TBL] [Abstract][Full Text] [Related]
27. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
28.
Islam SMS; Ryu HM; Sayeed HM; Byun HO; Jung JY; Kim HA; Suh CH; Sohn S
Front Immunol; 2021; 12():712312. PubMed ID: 34531862
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a mechanism that requires interleukin-15 receptor alpha.
O'Connell GC; Pistilli EE
Biochem Biophys Res Commun; 2015 Mar; 458(3):614-619. PubMed ID: 25681766
[TBL] [Abstract][Full Text] [Related]
30. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
31. Curcumin reduces the expression of interleukin 1β and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease.
Palizgir MT; Akhtari M; Mahmoudi M; Mostafaei S; Rezaiemanesh A; Shahram F
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):297-302. PubMed ID: 29806793
[TBL] [Abstract][Full Text] [Related]
32. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
33.
Anton OM; Peterson ME; Hollander MJ; Dorward DW; Arora G; Traba J; Rajagopalan S; Snapp EL; Garcia KC; Waldmann TA; Long EO
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):522-531. PubMed ID: 31871169
[TBL] [Abstract][Full Text] [Related]
34. Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo.
Finch DK; Midha A; Buchanan CL; Cochrane D; Craggs RI; Cruwys S; Grahames C; Kolbeck R; Lowe DC; Maltby J; Pattison DV; Vousden KA; Ward A; Sleeman MA; Mallinder PR
Br J Pharmacol; 2011 Jan; 162(2):480-90. PubMed ID: 20942844
[TBL] [Abstract][Full Text] [Related]
35. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
36. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
37. IL-15Rα is a determinant of muscle fuel utilization, and its loss protects against obesity.
Loro E; Seifert EL; Moffat C; Romero F; Mishra MK; Sun Z; Krajacic P; Anokye-Danso F; Summer RS; Ahima RS; Khurana TS
Am J Physiol Regul Integr Comp Physiol; 2015 Oct; 309(8):R835-44. PubMed ID: 26269523
[TBL] [Abstract][Full Text] [Related]
38. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 8 in Behçet's disease.
Itoh R; Takenaka T; Okitsu-Negishi S; Matsushima K; Mizoguchi M
J Dermatol; 1994 Jun; 21(6):397-404. PubMed ID: 8064002
[TBL] [Abstract][Full Text] [Related]
40. IL-15 receptor α signaling constrains the development of IL-17-producing γδ T cells.
Colpitts SL; Puddington L; Lefrançois L
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9692-7. PubMed ID: 26195801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
